Venables boards Ark as CEO
This article was originally published in Scrip
Executive Summary
Viral product focused Ark Therapeutics has appointed David Venables CEO with effect from 1 August 2012, replacing outgoing CEO Martyn Williams. Mr Venables joined Ark's board of directors in April this year (scripintelligence.com, 10 April 2012) from Intercell where he served as COO. Mr Williams joined the company in 1998 and has been CEO since mid-2010. He will leave Ark on 31 July.